Vigil Neuroscience Stock Profit Margin
| VIGL Stock | USD 3.01 0.18 5.64% |
Vigil Neuroscience fundamentals help investors to digest information that contributes to Vigil Neuroscience's financial success or failures. It also enables traders to predict the movement of Vigil Stock. The fundamental analysis module provides a way to measure Vigil Neuroscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vigil Neuroscience stock.
| Last Reported | Projected for Next Year |
Vigil | Profit Margin |
Vigil Neuroscience Company Profit Margin Analysis
Vigil Neuroscience's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Vigil Neuroscience has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Vigil Neuroscience ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vigil Neuroscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vigil Neuroscience's managers, analysts, and investors.Environmental | Governance | Social |
Vigil Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.4 | ||||
| Current Valuation | 32.31 M | ||||
| Shares Outstanding | 40.88 M | ||||
| Shares Owned By Insiders | 21.27 % | ||||
| Shares Owned By Institutions | 80.15 % | ||||
| Number Of Shares Shorted | 486.96 K | ||||
| Price To Book | 1.47 X | ||||
| EBITDA | (88.47 M) | ||||
| Net Income | (82.64 M) | ||||
| Cash And Equivalents | 148.91 M | ||||
| Cash Per Share | 5.27 X | ||||
| Total Debt | 13.85 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 21.35 X | ||||
| Book Value Per Share | 3.24 X | ||||
| Cash Flow From Operations | (70.36 M) | ||||
| Short Ratio | 5.31 X | ||||
| Earnings Per Share | (2.07) X | ||||
| Target Price | 15.88 | ||||
| Number Of Employees | 64 | ||||
| Beta | 1.93 | ||||
| Market Capitalization | 130.41 M | ||||
| Total Asset | 140.86 M | ||||
| Retained Earnings | (222.77 M) | ||||
| Working Capital | 110.25 M | ||||
| Net Asset | 140.86 M |
About Vigil Neuroscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vigil Neuroscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vigil Neuroscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vigil Neuroscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Vigil Neuroscience Piotroski F Score and Vigil Neuroscience Altman Z Score analysis. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.07) | Return On Assets (0.40) | Return On Equity (0.70) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.